TheraRadar

Pharma Intelligence, Simplified

← All Targets

norepinephrine transporter

2 drugs
PainCNS
Market Leader
TRAMADOL HYDROCHLORIDE
RUBICON RESEARCH
1
approved indications
2
Approved Drugs
2
Companies
2
Indications
2
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (2 companies)
All 2 approved drugs
Therapeutic area breakdown
Full indication list (2 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

RUBICON RESEARCH 1 drug
Johnson & Johnson 1 drug

By Therapeutic Area

Pain 1 drugs
CNS 1 drugs